Abstract:Background: Rhesus (Rh) alloimmunization occurs when an Rh negative mother is exposed to red blood cells (RBC) from an Rh positive fetus. The mother develops antibodies in the current pregnancy that attack Rh positive fetus in subsequent pregnancy, causing hemolytic disease of the fetus and newborn (HDFN). RhD is the most common antigen to result in fetal anemia requiring intrauterine transfusions (IUT). Although the traditional method of management and highly effective, IUTs carry significant risk particularly when performed early in gestation, potentially resulting in procedure-related fetal deaths. Intravenous immunoglobulin (IVIG) therapy may postpone or even replace invasive intrauterine treatment in fetuses of mothers with severe alloimmunization in previous pregnancies. Objective: To evaluate whether maternal administration of IVIG in high-risk Rhesus alloimmunized pregnancies is effective in delaying the need for IUTs as well as delaying the onset of severe fetal anemia and thus in diminishing its clinical consequences. Study design: A systematic literature search was conducted for maternal intravenous immunoglobulin administration in pregnancies with Rh isoimmunization in the following databases: Medline, Embase and Cochrane Library from 1946 to 2 February 2023. Inclusion criteria was studies done during pregnancy in which IVIG was administered to the mother in Rh alloimmunized pregnancies/fetal anemia. All non-english papers, animal papers, systematic reviews, editorials and studies in which IVIG was administered to non-pregnant patients were excluded. Data was extracted from these full texts and analyzed for inclusion based on the quantity of usable data and patient information. Extracted data included maternal antibody type and titer, number of maternal IVIG administrations, number of IUTs, and fetal Hb levels prior to first IUT and at delivery. Time interval (weeks) between IVIG and first IUT was also included in the extracted data along with gestational age at delivery. Individual patient data extraction was done for studies that provided data. Results: 16 studies were included in data analysis. Analysis of extracted data is ongoing.

Fetal Brain Injury in Rhesus Isoimmunization Fetus

Maternal isoimmunization associated fetal anemia: A case report

Severe Neonatal Anemia Affected by Massive Fetomaternal Hemorrhage: a Single-Center Retrospective Observational Study

Multiple intrauterine transfusions for fetal Rh hemolytic disease: a case report

Maternal IVIG Administration in Rhesus Alloimmunized Pregnancies: A Systematic Review

Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies

Neurosonographic Findings in Infants with Rhesus Hemolytic Disease of Newborn: A Prospective Observational Study

Fetal Brain Injury Associated with Parvovirus B19 Congenital Infection Requiring Intrauterine Transfusion

Prevalence of fetomaternal Rhesus incompatibility at the tertiary care hospital: a cross-sectional study

Management of Intracranial Hemorrhage and Skull Fracture After Blunt Intrauterine Trauma

An unexplained fetal intracranial hemorrhage with extensive and multifocal hemorrhagic lesions A case report

Management of Red Cell Alloimmunization in Pregnancy

Medical, Administrative, Financial, and Social Challenges in the Management of a Case of Hemolytic Disease of the Fetus Caused by a Rare Alloantibody in a Low-Resource Setting

Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization

Fetal intracranial hemorrhage and maternal vitamin K deficiency induced by total parenteral nutrition: A case report

Case Report: Prenatal Diagnosis of Fetal Intracranial Hemorrhage Due to Compound Mutations in the JAM3 Gene

[Congenital anomalies of the central nervous system--from the pediatric standpoint].

Hemolytic disease of the fetus and newborn-a perspective of immunohematology

Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma

Pathogenesis and Prevention of Fetal and Neonatal Brain Injury

Congenital infectious encephalopathies from the intrapartum period to postnatal life